乳腺癌中M1型巨噬细胞的浸润及其意义:基于METABRIC数据库分析与临床验证
研究比较T1N3期与T3N0期乳腺癌免疫微环境差异,METABRIC数据库分析显示T1N3期M1巨噬细胞占比15.85%、T3N0期M2巨噬细胞占比13.07%,M1占比差异有统计学意义(P=0.010)。临床标本验证显示T1N3期与T3N0期M1巨噬细胞中位密度分别为62.0和38.0个/mm²(P=0.002),M1巨噬细胞密度在T1N3期升高且与淋巴结转移有关。
要点
- METABRIC数据库分析中T1N3期M1巨噬细胞占比15.85%,为占比最高的浸润免疫细胞。
- T3N0期M2巨噬细胞占比13.07%,为占比最高的浸润免疫细胞。
- 临床标本验证T1N3期M1巨噬细胞中位密度62.0个/mm²高于T3N0期的38.0个/mm²(P=0.002)。
核心结论
- M1型巨噬细胞在T1N3期乳腺癌患者中密度升高,M1型巨噬细胞的浸润与乳腺癌的淋巴结转移有关。
研究设计与样本
- 从METABRIC数据库提取T1N3期(n=9)和T3N0期(n=11)乳腺癌患者的RNA-Seq表达数据和临床数据,采用CIBERSORT计算22种浸润性免疫细胞占比。
- 收集2011—2022年中国医学科学院肿瘤医院行根治性手术切除的乳腺癌组织标本,T1N3期77例、T3N0期58例,采用免疫组化双染技术检测M1型巨噬细胞密度以验证数据库分析结果。
主要发现
- METABRIC数据库分析显示T1N3期乳腺癌组织中占比最高的浸润性免疫细胞为M1巨噬细胞,占15.85%。
- T3N0期乳腺癌组织中占比最高的浸润性免疫细胞为M2巨噬细胞,占13.07%。
- T1N3期与T3N0期样本中M1巨噬细胞占比差异有统计学意义(P=0.010)。
- 免疫组化双染检测显示T1N3期和T3N0期乳腺癌组织中M1型巨噬细胞中位细胞密度分别为62.0和38.0个/mm²,差异有统计学意义(P=0.002)。
关键数值与推荐
- METABRIC数据库T1N3期M1巨噬细胞占比15.85%,T3N0期M2巨噬细胞占比13.07%,M1占比组间比较P=0.010。
- 临床标本T1N3期M1巨噬细胞中位密度62.0个/mm²,T3N0期38.0个/mm²,组间比较P=0.002。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the differences of immune microenvironment between stage T1N3 and stage T3N0 breast cancer patients and explore the relationship between M1 macrophage infiltration and lymph node metastasis in breast cancer. Methods: Clinical information and RNA-sequencing (RNA-Seq) expression data of stage T1N3 (n=9) and stage T3N0 (n=11) breast cancer patients were extracted from Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases. Using CIBERSORT, the proportions of 22 types of immune cells were calculated, and then the differences of immune cell infiltration between stage T1N3 and T3N0 patients were compared. From 2011 to 2022, pathologic specimens were collected from breast cancer patients who underwent curative resection at the Cancer Hospital, Chinese Academy of Medical Sciences, including 77 at stage T1N3 and 58 at stage T3N0.The METABRIC database analysis results were verified by examining the density of M1 macrophages in tissues using dual-staining immunohistochemistry. Results: METABRIC data analysis showed M1 macrophage was the highest proportion, 15.85% in stage T1N3 breast cancer; M2 macrophage was the highest proportion, 13.07% in stage T3N0 breast cancer.M1 macrophage proportions were statistically different between patients with stage T1N3 and stage T3N0 (P=0.010). The dual-staining immunohistochemistry analysis of breast cancer tissues showed M1 macrophage density (median) of 62.0 and 38.0 cells/mm(2) for stage T1N3 and T3N0, respectively. The difference was statistically significant (P=0.002). Conclusion: The density of M1 macrophages is notably higher in stage T1N3 patients and is associated with lymph node metastasis. 目的: 探讨T1N3期和T3N0期乳腺癌免疫微环境的差异及M1型巨噬细胞浸润与乳腺癌淋巴结转移的关系。 方法: 从国际乳腺癌协会分子分类(METABRIC)数据库中提取9例T1N3期和11例T3N0期乳腺癌患者的RNA-Seq测序数据和临床数据,采用CIBERSORT反卷积算法计算乳腺癌组织中22种浸润性免疫细胞的占比,比较T1N3期和T3N0期乳腺癌组织中免疫细胞浸润的差异。收集2011—2022年间在中国医学科学院肿瘤医院行根治性手术切除的乳腺癌组织标本,T1N3期77例,T3N0期58例,采用免疫组化双染技术检测组织中M1型巨噬细胞的细胞密度,以验证基于METABRIC数据库资料的分析结果。 结果: 对METABRIC数据库资料的分析显示,在T1N3期乳腺癌组织中占比最高的浸润性免疫细胞为M1巨噬细胞,占15.85%;在T3N0期乳腺癌组织中占比最高的浸润性免疫细胞为M2巨噬细胞,占13.07%。T1N3期和T3N0期样本中M1巨噬细胞的占比差异有统计学意义(P=0.010)。乳腺癌组织标本的免疫组化双染检测结果显示,T1N3期和T3N0期乳腺癌组织中M1型巨噬细胞的中位细胞密度分别为62.0和38.0个/mm(2),差异有统计学意义(P=0.002)。 结论: M1型巨噬细胞在T1N3期乳腺癌患者中密度升高,M1型巨噬细胞的浸润与乳腺癌的淋巴结转移有关。.
引用
- Lei HZ, Yuan P, Jia J, et al. [Infiltration and significance of M1 macrophage in breast cancer: an analysis of METABRIC database and clinical validation]. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 37188626. doi:10.3760/cma.j.cn112152-20221114-00756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。